Skip to Main Content

Paper Details

Single Center Experience with a 4-Week <sup>177</sup>Lu-PSMA-617 Treatment Interval in Patients with Metastatic Castration-Resistant Prostate Cancer.
Cancers (Basel)
2
2022
Author NameAffiliation
Juha KononenDocrates Cancer Center
  • 1 - 1

Datasets

Release 1.2